Home/Filings/4/0001169245-21-000069
4//SEC Filing

Arnold Susan Elizabeth 4

Accession 0001169245-21-000069

CIK 0001169245other

Filed

Jul 13, 8:00 PM ET

Accepted

Jul 14, 7:06 PM ET

Size

4.7 KB

Accession

0001169245-21-000069

Insider Transaction Report

Form 4
Period: 2021-07-12
Arnold Susan Elizabeth
VP, Preclinical and Chem.
Transactions
  • Award

    Common Stock

    2021-07-12$1.74/sh+4,519$7,86327,760 total

Issuer

PhaseBio Pharmaceuticals Inc

CIK 0001169245

Entity typeother

Related Parties

1
  • filerCIK 0001755746

Filing Metadata

Form type
4
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 7:06 PM ET
Size
4.7 KB